1
/
of
0
FDA Records – Hyvisc for Equine Osteoarthritis (Clinical Trial Endpoints, Efficacy, Safety, etc.)
FDA Records – Hyvisc for Equine Osteoarthritis (Clinical Trial Endpoints, Efficacy, Safety, etc.)
Regular price
$69.00 USD
Regular price
Sale price
$69.00 USD
Unit price
/
per
Original Request Contents: Request all records related to Hyvisc, a hyaluronic acid-based viscous fluid used in the management of joint dysfunction in horses with equine osteoarthritis, including clinical trial endpoints, efficacy, safety, improvement timepoints, lameness scores, flexion, and gross effusion
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details